Viacor

About:

Viacor develops catheter-based techniques for the treatment of heart valve disease contributing to congestive heart failure.

Website: http://www.viacorinc.com

Top Investors: New Enterprise Associates, Canaan Partners

Description:

Viacor is a development stage company dedicated to pioneering catheter-based techniques for the treatment of heart valve disease contributing to congestive heart failure (CHF).

Total Funding Amount:

$34M

Headquarters Location:

Wilmington, Massachusetts, United States

Founded Date:

1999-12-01

Contact Email:

info(AT)viacorinc.com

Founders:

Marc Gillinov, Todd Davenport

Number of Employees:

11-50

Last Funding Date:

2010-11-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai